» Articles » PMID: 25809098

Anthropometry in 5- to 9-Year-Old Greenlandic and Ukrainian Children in Relation to Prenatal Exposure to Perfluorinated Alkyl Substances

Abstract

Background: In some animal studies, perfluorinated alkyl substances are suggested to induce weight gain. Human epidemiological studies investigating these associations are sparse.

Objective: We examined pregnancy serum concentrations of perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) and the prevalence of offspring overweight (> 1 SD) and waist-to-height ratio (WHtR) > 0.5 at 5-9 years of age.

Methods: Sera from 1,022 pregnant women enrolled in the INUENDO cohort (2002-2004) from Greenland and Kharkiv (Ukraine) were analyzed for PFOA and PFOS using liquid chromatography-tandem mass spectrometry. Relative risks (RR) of being overweight and having WHtR > 0.5 in relation to continuous and categorized (tertiles) PFOA and PFOS were calculated at follow-up (2010-2012) using generalized linear models.

Results: Pooled PFOA median (range) was 1.3 (0.2-5.1) and PFOS median (range) was 10.8 (0.8-73.0) ng/mL. For each natural logarithm-unit (ln-unit) increase of pregnancy PFOA, the adjusted RR of offspring overweight was 1.11 [95% confidence interval (CI): 0.82, 1.53] in Greenlandic children. In Ukrainian children, the adjusted RR of offspring overweight was 1.02 (95% CI: 0.72, 1.44) for each ln-unit increase of pregnancy PFOA. Prenatal exposure to PFOS was not associated with overweight in country-specific or pooled analysis. The adjusted RR of having WHtR > 0.5 for each ln-unit increase of prenatal exposure to PFOA was 1.30 (95% CI: 0.97, 1.74) in the pooled analysis. For 1-ln-unit increase of prenatal exposure to PFOS, the adjusted RR of having a WHtR > 0.5 was 1.38 (95% CI: 1.05, 1.82) in the pooled analysis.

Conclusions: The results indicate that prenatal PFOA and PFOS exposures may be associated with child waist-to-height ratio > 0.5. Prenatal PFOA and PFOS exposures were not associated with overweight.

Citing Articles

Per- and poly-fluoroalkyl substances as forever chemicals in drinking water: Unraveling the nexus with obesity and endocrine disruption - A mini review.

Pezeshki H, Rajabi S, Hashemi M, Moradalizadeh S, Nasab H Heliyon. 2025; 11(4):e42782.

PMID: 40066031 PMC: 11891678. DOI: 10.1016/j.heliyon.2025.e42782.


Per- and Polyfluoroalkyl Substances and Outcomes Related to Metabolic Syndrome: A Review of the Literature and Current Recommendations for Clinicians.

Hall A, Braun J Am J Lifestyle Med. 2025; 19(2):211-229.

PMID: 39981556 PMC: 11836584. DOI: 10.1177/15598276231162802.


Hidden link between endocrine-disrupting chemicals and pediatric obesity.

Shin M, Kim S Clin Exp Pediatr. 2024; 68(3):199-222.

PMID: 39608365 PMC: 11884955. DOI: 10.3345/cep.2024.00556.


Key recommendations and research priorities of the 2021 AMAP human health assessment.

Khoury C, Weihe P Int J Circumpolar Health. 2024; 83(1):2408057.

PMID: 39360677 PMC: 11451291. DOI: 10.1080/22423982.2024.2408057.


Cross-cutting studies of per- and polyfluorinated alkyl substances (PFAS) in Arctic wildlife and humans.

Lohmann R, Abass K, Bonefeld-Jorgensen E, Bossi R, Dietz R, Ferguson S Sci Total Environ. 2024; 954:176274.

PMID: 39304148 PMC: 11567803. DOI: 10.1016/j.scitotenv.2024.176274.


References
1.
Schellong K, Schulz S, Harder T, Plagemann A . Birth weight and long-term overweight risk: systematic review and a meta-analysis including 643,902 persons from 66 studies and 26 countries globally. PLoS One. 2012; 7(10):e47776. PMC: 3474767. DOI: 10.1371/journal.pone.0047776. View

2.
Vanden Heuvel J, Kuslikis B, Van Rafelghem M, Peterson R . Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. J Biochem Toxicol. 1991; 6(2):83-92. DOI: 10.1002/jbt.2570060202. View

3.
Du G, Huang H, Hu J, Qin Y, Wu D, Song L . Endocrine-related effects of perfluorooctanoic acid (PFOA) in zebrafish, H295R steroidogenesis and receptor reporter gene assays. Chemosphere. 2013; 91(8):1099-106. DOI: 10.1016/j.chemosphere.2013.01.012. View

4.
Bluher S, Molz E, Wiegand S, Otto K, Sergeyev E, Tuschy S . Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. J Clin Endocrinol Metab. 2013; 98(8):3384-93. DOI: 10.1210/jc.2013-1389. View

5.
Andersen C, Fei C, Gamborg M, Nohr E, Sorensen T, Olsen J . Prenatal exposures to perfluorinated chemicals and anthropometry at 7 years of age. Am J Epidemiol. 2013; 178(6):921-7. DOI: 10.1093/aje/kwt057. View